118 related articles for article (PubMed ID: 11567026)
21. The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.
Zhu H; Jia Z; Mahaney JE; Ross D; Misra HP; Trush MA; Li Y
Cardiovasc Toxicol; 2007; 7(3):202-11. PubMed ID: 17901563
[TBL] [Abstract][Full Text] [Related]
22. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo.
Kapinya KJ; Harms U; Harms C; Blei K; Katchanov J; Dirnagl U; Hörtnagl H
J Neurochem; 2003 Mar; 84(5):1028-39. PubMed ID: 12603827
[TBL] [Abstract][Full Text] [Related]
23. p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).
Dudley BF; Winston GW
Arch Biochem Biophys; 1995 Feb; 316(2):879-85. PubMed ID: 7532387
[TBL] [Abstract][Full Text] [Related]
24. Expression and activity of NAD(P)H:quinone oxidoreductase (NMO1) in human osteoblastic cells.
Collin P; Lomri A; Marie PJ
Bone; 2001 Jan; 28(1):9-13. PubMed ID: 11165937
[TBL] [Abstract][Full Text] [Related]
25. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
Powis G; See KL; Santone KS; Melder DC; Hodnett EM
Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
[TBL] [Abstract][Full Text] [Related]
26. Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation.
Lindemer BJ; Bongard RD; Hoffmann R; Baumgardt S; Gonzalez FJ; Merker MP
Am J Physiol Lung Cell Mol Physiol; 2011 May; 300(5):L773-80. PubMed ID: 21296895
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity.
Megarity CF; Timson DJ
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431515
[TBL] [Abstract][Full Text] [Related]
28. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
Dehn DL; Siegel D; Zafar KS; Reigan P; Swann E; Moody CJ; Ross D
Mol Cancer Ther; 2006 Jul; 5(7):1702-9. PubMed ID: 16891456
[TBL] [Abstract][Full Text] [Related]
29. Reduction of nitroaromatic compounds by NAD(P)H:quinone oxidoreductase (NQO1): the role of electron-accepting potency and structural parameters in the substrate specificity.
Miseviciene L; Anusevicius Z; Sarlauskas J; Cenas N
Acta Biochim Pol; 2006; 53(3):569-76. PubMed ID: 16929382
[TBL] [Abstract][Full Text] [Related]
30. Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-alpha-induced migration of human vascular smooth muscle cells.
Lee SO; Chang YC; Whang K; Kim CH; Lee IS
Cardiovasc Res; 2007 Nov; 76(2):331-9. PubMed ID: 17669387
[TBL] [Abstract][Full Text] [Related]
31. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
32. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
[TBL] [Abstract][Full Text] [Related]
33. Arsenite pretreatment enhances the cytotoxicity of mitomycin C in human cancer cell lines via increased NAD(P)H quinone oxidoreductase 1 expression.
Lin YL; Ho IC; Su PF; Lee TC
Toxicol Appl Pharmacol; 2006 Aug; 214(3):309-17. PubMed ID: 16494910
[TBL] [Abstract][Full Text] [Related]
34. Human NAD(P)H:quinone oxidoreductase inhibition by flavonoids in living cells.
Lee YY; Westphal AH; de Haan LH; Aarts JM; Rietjens IM; van Berkel WJ
Free Radic Biol Med; 2005 Jul; 39(2):257-65. PubMed ID: 15964517
[TBL] [Abstract][Full Text] [Related]
35. NAD(P)H:quinone oxidoreductase (NQO1) protects astroglial cells against L-dopa toxicity.
Drukarch B; Jongenelen CA; van Muiswinkel FL
Adv Exp Med Biol; 2001; 500():237-40. PubMed ID: 11764945
[No Abstract] [Full Text] [Related]
36. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial production of reactive oxygen species mediate dicumarol-induced cytotoxicity in cancer cells.
Du J; Daniels DH; Asbury C; Venkataraman S; Liu J; Spitz DR; Oberley LW; Cullen JJ
J Biol Chem; 2006 Dec; 281(49):37416-26. PubMed ID: 17040906
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of hemeoxygenase-1 and NQO1 expression.
Park JS; Jung JS; Jeong YH; Hyun JW; Le TK; Kim DH; Choi EC; Kim HS
J Neurochem; 2011 Dec; 119(5):909-19. PubMed ID: 21781119
[TBL] [Abstract][Full Text] [Related]
39. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
[TBL] [Abstract][Full Text] [Related]
40. Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo.
Sharp SY; Kelland LR; Valenti MR; Brunton LA; Hobbs S; Workman P
Mol Pharmacol; 2000 Nov; 58(5):1146-55. PubMed ID: 11040064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
